Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 25 | SFEBES2011 | Next issue

Society for Endocrinology BES 2011

Oral Communications

Pituitary and thyroid

Development of a novel mass spectroscopy-based method for determining serum IGF1: assessment in a cohort of newly diagnosed subjects with acromegaly
1Addenbrookes Hospital, Cambridge, UK; 2Quotient Bioresearch Ltd, Fordham, Cambridgeshire, UK; 3Royal Surrey County Hospital, Guildford, UK.
Determination of method-specific normal cortisol responses to the short Synacthen test
1University Hospital of Wales, Cardiff, UK; 2Cardiff University, Cardiff, UK; 3Welsh External Quality Assurance Scheme Laboratory, Cardiff, UK; 4Royal Gwent Hospital, Newport, UK; 5Prince Charles Hospital, Merthyr Tydfil, UK; 6Bristol Royal Infirmary, Bristol, UK; 7Southampton General Hospital, Southampton, UK.
miR-107 inhibits the expression of aryl hydrocarbon receptor interacting protein (AIP) and is potentially involved in pituitary tumorigenesis
1Department of Endocrinology, Barts and the London School of Medicine, Queen Mary University of London, London, UK; 2Second Department of Medicine, Faculty of Medicine, Semmelweis University, Budapest, Hungary; 3Molecular Medicine Research Group, Hungarian Academy of Sciences and Second Department of Medicine, Faculty of Medicine, Semmelweis University, Budapest, Hungary.
Metastatic characteristics and radiosensitivity of thyroid carcinoma cells depends on HIF-1 and PI3K signalling in vitro and in vivo
1School of Pharmacy, University of Manchester, Manchester, Lancashire, UK; 2Department of Endocrinology, Christie Hospital, Manchester, Lancashire, UK.
Thyroid dysfunction and clot structure: a mechanism for increased thrombotic risk in hyperthyroid individuals?
1Division of Cardiovascular and Diabetes Research, Leeds Institute of Genetics, Health and Therapeutics, University of Leeds, Leeds, West Yorkshire, UK; 2Department of Endocrinology, Leeds Teaching Hospital NHS Trust, Leeds General Infirmary, Leeds, West Yorkshire, UK; 3Department of Internal Medicine, Slotervaart Hospital, Amsterdam, The Netherlands; 4Institute of Human Genetics, International Centre for Life, Newcastle-upon-Tyne, UK.
Assessment of the UK iodine status: a National Survey
1Royal Free Hampstead NHS Trust, London, UK; 2University Hospital Wales, Cardiff, UK; 3University College, Dublin, Ireland; 4University of Birmingham, Birmingham, UK; 5Imperial College, London, UK; 6Royal Infirmary, Belfast, UK; 7University of Newcastle, Newcastle-upon-Tyne, UK; 8Gateshead Health NHS Foundation Trust, Gateshead, UK; 9University of Glasgow, Glasgow, UK; 10Institute of Medical Genetics, Glasgow, UK; 11Aberdeen Royal infirmary, Aberdeen, UK; 12Royal Devon and Exeter Hospital, Exeter, UK; 13University of Dundee, Dundee, UK; 14Aalborg Hospital, Aalborg, Denmark.